Microcalcifications in Atherosclerotic Plaque

动脉粥样硬化斑块中的微钙化

基本信息

  • 批准号:
    10411607
  • 负责人:
  • 金额:
    $ 15.7万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-05 至 2026-07-31
  • 项目状态:
    未结题

项目摘要

SUMMARY Human fibroatheroma (FA) cap rupture leads to the formation of an occluding thrombus, myocardial infarction (MI) and sudden death in more than half a million Americans every year. A vulnerable plaque is defined as a positively remodeled lesion, rich in vasa-vasorum, characterized by smooth muscle cell apoptosis, and containing a lipid rich pool with a fibrous cap that is infiltrated by macrophages. The current paradigm is that a cap thickness < 65 µm (thin-cap FA or TCFA) is the key determinant of plaque vulnerability, and rupture occurs when the cap tissue experiences a peak stress greater than 300 kPa. However, there are several other factors that play an important role in the FA cap rupture, including atheroma morphology, biological environment, tissue composition and mechanical forces. Indeed, whether the cap thickness is the single most important criterion predicting plaque vulnerability is unclear, and the underlying mechanisms for atheroma cap rupture are still insufficiently understood. Vascular calcification has emerged among the factors that play an important role in the stability of plaque rupture. For many decades, cardiovascular calcification has been considered as a passive process, accompanying atheroma progression, correlated with plaque burden, and apparently without a major role on plaque vulnerability. Clinical and pathological analyses have previously focused on the total amount of calcification (calcified area in a whole atheroma cross section), and whether more calcification means higher risk of plaque rupture or not. However, this paradigm has been changing in the last decade or so. Recent research has focused on the presence of microcalcifications (µCalcs) in the atheroma, and more importantly on whether clusters of µCalcs are located in the cap of the atheroma. While the vast majority of µCalcs are found in the lipid pool or necrotic core, they are inconsequential to vulnerable plaque. We have also demonstrated to date the existence of thousands of μCalcs primarily in non-ruptured human atheroma caps using µCT imaging, and that they behave as an intensifier of the background circumferential stress in the cap. However, the similar X-ray absorption properties of a thrombus and soft tissue complicates the analysis of μCalcs in ruptured FAs. To overcome this limitation, we have developed a high-resolution contrast-enhanced µCT (CEµCT) approach to investigate whether μCalcs co-localize with the site of FA cap rupture, in cases where an occluding thrombus is formed, followed by myocardial infarction. The working hypothesis is that μCalcs in the FA cap has a major effect on the FA cap rupture threshold. To test this hypothesis we propose to (1) determine the sensitivity and specificity of μCalcs in the FA cap as a key biomarker of fibroatheroma rupture risk in human coronary vessels, and (2) to characterize the increase in FA rupture risk due to μCalcs in the ApoE KO mice. If successful, the proposed study will increase our understanding on vulnerable plaque rupture biomechanics and provide an alternative paradigm for vulnerable plaque that will consider the effect of μCalcs in human atheroma cap rupture risk.
总结 人纤维粥样硬化(FA)帽破裂导致闭塞性血栓形成,心肌梗死 (MI)每年有超过50万美国人死于猝死。易损斑块定义为 阳性重塑病变,血管丰富,以平滑肌细胞凋亡为特征,和 含有富含脂质的池,其具有被巨噬细胞浸润的纤维帽。目前的范例是, 帽厚度< 65 µm(薄帽FA或TCFA)是斑块易损性的关键决定因素, 当帽组织经受大于300 kPa的峰值应力时。然而,还有其他几个因素 在FA帽破裂中起重要作用的因素,包括动脉粥样硬化形态、生物环境、组织 组成和机械力。事实上,是否帽厚度是唯一最重要的标准 预测斑块易损性尚不清楚,动脉粥样硬化帽破裂的潜在机制仍不清楚。 不够理解。 血管钙化已成为斑块破裂稳定性的重要因素之一。 几十年来,心血管钙化一直被认为是一个被动的过程, 动脉粥样硬化进展,与斑块负荷相关,显然对斑块无主要作用 易损性.临床和病理学分析以前主要集中在钙化的总量上 (整个动脉粥样硬化横截面中的钙化区域),以及更多的钙化是否意味着更高的斑块风险 破裂与否。然而,这种模式在过去十年左右的时间里一直在发生变化。最近的研究集中在 动脉粥样硬化中微钙化(µCalcs)的存在,更重要的是, µCalcs位于动脉粥样硬化帽中。虽然绝大多数µ Calc存在于脂质池中, 坏死的核心,他们是无关紧要的脆弱斑块。迄今为止,我们还证明了 使用µCT成像,主要在未破裂的人类动脉粥样硬化帽中存在数千μ Calc, 作为帽中的背景周向应力的增强器。然而,类似的X射线吸收 血栓和软组织的特性使破裂FA中μCalcs的分析复杂化。为了克服这个 局限性,我们开发了一种高分辨率对比增强µCT(CEµCT)方法来研究 在形成闭塞性血栓的情况下,μCalcs是否与FA帽破裂部位共定位, 然后是心肌梗塞工作假设是FA帽中的μCalcs对 FA帽破裂阈值。为了验证这一假设,我们建议(1)确定以下方法的灵敏度和特异性: FA帽中的μCalcs作为人类冠状动脉血管中纤维粥样硬化破裂风险的关键生物标志物,以及(2) 表征ApoE KO小鼠中μ Calc导致的FA破裂风险增加。如果成功,建议 这项研究将增加我们对易损斑块破裂生物力学的理解, 脆弱斑块的范例,将考虑μCalcs对人类动脉粥样硬化帽破裂风险的影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Luis Cardoso其他文献

Luis Cardoso的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Luis Cardoso', 18)}}的其他基金

Acquisition of a Verasonics Vantage 256 Research Ultrasound Platform
收购 Verasonics Vantage 256 研究超声平台
  • 批准号:
    10415588
  • 财政年份:
    2022
  • 资助金额:
    $ 15.7万
  • 项目类别:
Acquisition of Colaborative Robot System for Ultrasound Research
采购用于超声研究的协作机器人系统
  • 批准号:
    10798904
  • 财政年份:
    2022
  • 资助金额:
    $ 15.7万
  • 项目类别:
Mechanical Function of Trabecular Bone: Bone Loss Assessment Beyond BMD
小梁骨的机械功能:BMD 之外的骨丢失评估
  • 批准号:
    8630400
  • 财政年份:
    2014
  • 资助金额:
    $ 15.7万
  • 项目类别:
Mechanical Function of Trabecular Bone: Bone Loss Assessment Beyond BMD
小梁骨的机械功能:BMD 之外的骨丢失评估
  • 批准号:
    9236194
  • 财政年份:
    2014
  • 资助金额:
    $ 15.7万
  • 项目类别:
Mechanical Function of Trabecular Bone: Bone Loss Assessment Beyond BMD
小梁骨的机械功能:BMD 之外的骨丢失评估
  • 批准号:
    8829243
  • 财政年份:
    2014
  • 资助金额:
    $ 15.7万
  • 项目类别:
Mechanical Function of Trabecular Bone: Bone Loss Assessment Beyond BMD
小梁骨的机械功能:BMD 之外的骨丢失评估
  • 批准号:
    9044771
  • 财政年份:
    2014
  • 资助金额:
    $ 15.7万
  • 项目类别:
Age Related Bone Loss Assessed by Ultrasound Tomography: Bone Quality Beyond BMD
通过超声断层扫描评估与年龄相关的骨质流失:骨质量超越 BMD
  • 批准号:
    8043597
  • 财政年份:
    2009
  • 资助金额:
    $ 15.7万
  • 项目类别:
Age Related Bone Loss Assessed by Ultrasound Tomography: Bone Quality Beyond BMD
通过超声断层扫描评估与年龄相关的骨质流失:骨质量超越 BMD
  • 批准号:
    7560242
  • 财政年份:
    2009
  • 资助金额:
    $ 15.7万
  • 项目类别:
Age Related Bone Loss Assessed by Ultrasound Tomography: Bone Quality Beyond BMD
通过超声断层扫描评估与年龄相关的骨质流失:骨质量超越 BMD
  • 批准号:
    7760096
  • 财政年份:
    2009
  • 资助金额:
    $ 15.7万
  • 项目类别:

相似海外基金

COOPERATIVE AGREEMENT WITH THE PAN AMERICAN HEALTH ORGANIZATION
与泛美卫生组织的合作协议
  • 批准号:
    9065935
  • 财政年份:
    2014
  • 资助金额:
    $ 15.7万
  • 项目类别:
COOPERATIVE AGREEMENT WITH THE PAN AMERICAN HEALTH ORGANIZATION
与泛美卫生组织的合作协议
  • 批准号:
    8788900
  • 财政年份:
    2014
  • 资助金额:
    $ 15.7万
  • 项目类别:
Cooperative Agreement with Pan American Health Organization (PAHO)
与泛美卫生组织(PAHO)的合作协议
  • 批准号:
    8732111
  • 财政年份:
    2010
  • 资助金额:
    $ 15.7万
  • 项目类别:
Cooperative Agreement with Pan American Health Organization (PAHO)
与泛美卫生组织(PAHO)的合作协议
  • 批准号:
    8145578
  • 财政年份:
    2010
  • 资助金额:
    $ 15.7万
  • 项目类别:
Cooperative Agreement with Pan American Health Organization (PAHO)
与泛美卫生组织(PAHO)的合作协议
  • 批准号:
    8529690
  • 财政年份:
    2010
  • 资助金额:
    $ 15.7万
  • 项目类别:
Cooperative Agreement with Pan American Health Organization (PAHO)
与泛美卫生组织(PAHO)的合作协议
  • 批准号:
    8333850
  • 财政年份:
    2010
  • 资助金额:
    $ 15.7万
  • 项目类别:
Cooperative Agreement with Pan American Health Organization (PAHO)
与泛美卫生组织(PAHO)的合作协议
  • 批准号:
    8542496
  • 财政年份:
    2010
  • 资助金额:
    $ 15.7万
  • 项目类别:
Cooperative Agreement with Pan American Health Organization (PAHO)
与泛美卫生组织(PAHO)的合作协议
  • 批准号:
    8140030
  • 财政年份:
    2010
  • 资助金额:
    $ 15.7万
  • 项目类别:
AMERICAN SAMOA AFFILIATED COLLABORATIVE PERFORMANCE AGREEMENT FOR TOBACCO CONTROL
美属萨摩亚附属烟草控制合作履约协议
  • 批准号:
    8450040
  • 财政年份:
    2009
  • 资助金额:
    $ 15.7万
  • 项目类别:
AMERICAN SAMOA AFFILIATED COLLABORATIVE PERFORMANCE AGREEMENT FOR TOBACCO CONTROL
美属萨摩亚附属烟草控制合作履约协议
  • 批准号:
    8054728
  • 财政年份:
    2009
  • 资助金额:
    $ 15.7万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了